Esther Landhuis is a freelance science writer in the San Francisco Bay Area. Her work has appeared in Scientific American, Science, Science News for Students and Alzheimer Research Forum, among other publications. She has extensive experience reporting on neurodegenerative brain disorders. She has a Ph.D. in immunology from Harvard University. She tweets @elandhuis.
Esther Landhuis
From this contributor
Elizabeth Berry-Kravis: Running a marathon for fragile X syndrome
Elizabeth Berry-Kravis has spent decades uncovering molecular clues to fragile X syndrome and crafting trials of treatments. Her efforts are paying off.
Elizabeth Berry-Kravis: Running a marathon for fragile X syndrome
By
Esther Landhuis
26 May 2021 | 10 min read
Drug boosts cognition in men with fragile X syndrome
A drug that prevents an enzyme from breaking down a key molecule involved in learning and memory improved cognition and behavior in a small study of men with fragile X syndrome.
Drug boosts cognition in men with fragile X syndrome
By
Esther Landhuis
29 April 2021 | 4 min read
Gene-editing tool used to map lineage of cells
Researchers have repurposed CRISPR, the popular gene-editing tool, for tracing cell lineages in whole organisms.
Gene-editing tool used to map lineage of cells
By
Esther Landhuis
29 June 2016 | 3 min read
Explore more from The Transmitter
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
By
Anna Victoria Molofsky
17 January 2025 | 5 min read
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
By
Angie Voyles Askham
16 January 2025 | 6 min read
X marks the spot in search for autism variants
Genetic variants on the X chromosome, including those in the gene DDX53, contribute to autism’s gender imbalance, two new studies suggest.
X marks the spot in search for autism variants
Genetic variants on the X chromosome, including those in the gene DDX53, contribute to autism’s gender imbalance, two new studies suggest.
By
Holly Barker
16 January 2025 | 6 min read